These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17761766)

  • 21. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
    Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
    Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
    Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
    Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreases in growth hormone receptor signal transduction contribute to the decline in insulin-like growth factor I gene expression with age.
    Xu X; Bennett SA; Ingram RL; Sonntag WE
    Endocrinology; 1995 Oct; 136(10):4551-7. PubMed ID: 7664676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A conformationally sensitive GHR [growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysis.
    Jiang J; Wang X; He K; Li X; Chen C; Sayeski PP; Waters MJ; Frank SJ
    Mol Endocrinol; 2004 Dec; 18(12):2981-96. PubMed ID: 15345746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
    Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
    Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation.
    Yang N; Wang X; Jiang J; Frank SJ
    Mol Endocrinol; 2007 Jul; 21(7):1642-55. PubMed ID: 17456794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced proteolysis of rabbit growth hormone (GH) receptor substituted with mouse GH receptor cleavage site.
    Wang X; He K; Gerhart M; Jiang J; Paxton RJ; Menon RK; Black RA; Baumann G; Frank SJ
    Mol Endocrinol; 2003 Oct; 17(10):1931-43. PubMed ID: 12829808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone receptor ubiquitination, endocytosis, and degradation are independent of signal transduction via Janus kinase 2.
    Alves dos Santos CM; ten Broeke T; Strous GJ
    J Biol Chem; 2001 Aug; 276(35):32635-41. PubMed ID: 11418602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ubiquitin-proteasome pathway and the regulation of growth hormone receptor availability.
    Strous GJ; van Kerkhof P
    Mol Cell Endocrinol; 2002 Nov; 197(1-2):143-51. PubMed ID: 12431807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: insights into receptor triggering.
    Yang N; Langenheim JF; Wang X; Jiang J; Chen WY; Frank SJ
    Mol Endocrinol; 2008 Apr; 22(4):978-88. PubMed ID: 18096690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of JAK2 protein expression by chronic, pulsatile GH administration in vivo: a possible mechanism for ligand enhancement of signal transduction.
    Zhou Y; Wang X; Hadley J; Corey SJ; Vasilatos-Younken R
    Gen Comp Endocrinol; 2005 Nov; 144(2):128-39. PubMed ID: 15993410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoplasmic reticulum stress prolongs GH-induced Janus kinase (JAK2)/signal transducer and activator of transcription (STAT5) signaling pathway.
    Flores-Morales A; Fernández L; Rico-Bautista E; Umana A; Negrín C; Zhang JG; Norstedt G
    Mol Endocrinol; 2001 Sep; 15(9):1471-83. PubMed ID: 11518796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased growth hormone receptor (GHR) degradation due to over-expression of cytokine inducible SH2 domain-containing protein (CIS) as a cause of GH transduction defect (GHTD).
    Gil AP; Kostopoulou E; Karageorgou I; Kamzelas K; Spiliotis BE
    J Pediatr Endocrinol Metab; 2012; 25(9-10):897-908. PubMed ID: 23426819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor.
    Frank SJ; Yi W; Zhao Y; Goldsmith JF; Gilliland G; Jiang J; Sakai I; Kraft AS
    J Biol Chem; 1995 Jun; 270(24):14776-85. PubMed ID: 7540178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The growth hormone receptor interacts with its sheddase, the tumour necrosis factor-alpha-converting enzyme (TACE).
    Schantl JA; Roza M; Van Kerkhof P; Strous GJ
    Biochem J; 2004 Jan; 377(Pt 2):379-84. PubMed ID: 14519102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of liver JAK2-STAT5b signaling by the female plasma pattern of continuous growth hormone stimulation.
    Gebert CA; Park SH; Waxman DJ
    Mol Endocrinol; 1999 Feb; 13(2):213-27. PubMed ID: 9973252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the cytokine-induced SH2 domain-containing protein CIS in growth hormone receptor internalization.
    Landsman T; Waxman DJ
    J Biol Chem; 2005 Nov; 280(45):37471-80. PubMed ID: 16154995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of glucose transport and c-fos and egr-1 expression in cells with mutated or endogenous growth hormone receptors.
    Gong TW; Meyer DJ; Liao J; Hodge CL; Campbell GS; Wang X; Billestrup N; Carter-Su C; Schwartz J
    Endocrinology; 1998 Apr; 139(4):1863-71. PubMed ID: 9528972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ubiquitin system-dependent regulation of growth hormone receptor signal transduction.
    Strous GJ; dos Santos CA; Gent J; Govers R; Sachse M; Schantl J; van Kerkhof P
    Curr Top Microbiol Immunol; 2004; 286():81-118. PubMed ID: 15645711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of prolactin receptor in GH signaling in breast cancer cells.
    Xu J; Sun D; Jiang J; Deng L; Zhang Y; Yu H; Bahl D; Langenheim JF; Chen WY; Fuchs SY; Frank SJ
    Mol Endocrinol; 2013 Feb; 27(2):266-79. PubMed ID: 23192981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.